Global Nucleic Acid-Based Multiplex Assays Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Nucleic Acid-Based Multiplex Assays Market Research Report 2024
Multiplex assay is a procedure in which various analytes (such as proteins, biomolecules, growth factors, cytokines, chemokines, and others) are profiled by detecting and quantifying them simultaneously. This assay is used to amplify multiple targets in a polymerase chain reaction (PCR) and collect more information from minute quantities of proteins or other analytes in lesser time as compared to conventional methods such as ELISA. Multiplex assays are widely used for pathogen identification, mutation analysis, RNA detection, gene detection analysis, linkage analysis, forensic studies, and others.
According to Mr Accuracy reports’s new survey, global Nucleic Acid-Based Multiplex Assays market is projected to reach US$ million in 2034, increasing from US$ million in 2024, with the CAGR of % during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Nucleic Acid-Based Multiplex Assays market research.
Key companies engaged in the Nucleic Acid-Based Multiplex Assays industry include Luminex, Thermo Fisher Scientific, Illumina, Bio-Rad Lab, QIAGEN, BD, Abcam, Seegene and Meso Scale Diagnostics, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2024.
When refers to consumption region, % value of Nucleic Acid-Based Multiplex Assays were sold to North America, Europe and Asia Pacific in 2024. Moreover, China, plays a key role in the whole Nucleic Acid-Based Multiplex Assays market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Nucleic Acid-Based Multiplex Assays market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Luminex
Thermo Fisher Scientific
Illumina
Bio-Rad Lab
QIAGEN
BD
Abcam
Seegene
Meso Scale Diagnostics
Randox Laboratories
Segment by Type
Reagents & Consumables
Instruments & Accessories
Software & Services
Companion Diagnostics
Research & Development
Clinical Diagnostics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Nucleic Acid-Based Multiplex Assays report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to Mr Accuracy reports’s new survey, global Nucleic Acid-Based Multiplex Assays market is projected to reach US$ million in 2034, increasing from US$ million in 2024, with the CAGR of % during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Nucleic Acid-Based Multiplex Assays market research.
Key companies engaged in the Nucleic Acid-Based Multiplex Assays industry include Luminex, Thermo Fisher Scientific, Illumina, Bio-Rad Lab, QIAGEN, BD, Abcam, Seegene and Meso Scale Diagnostics, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2024.
When refers to consumption region, % value of Nucleic Acid-Based Multiplex Assays were sold to North America, Europe and Asia Pacific in 2024. Moreover, China, plays a key role in the whole Nucleic Acid-Based Multiplex Assays market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Nucleic Acid-Based Multiplex Assays market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Luminex
Thermo Fisher Scientific
Illumina
Bio-Rad Lab
QIAGEN
BD
Abcam
Seegene
Meso Scale Diagnostics
Randox Laboratories
Segment by Type
Reagents & Consumables
Instruments & Accessories
Software & Services
Segment by Application
Companion Diagnostics
Research & Development
Clinical Diagnostics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Nucleic Acid-Based Multiplex Assays report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source